Tower View Wealth Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.63M | Buy |
3,006
+273
| +10% | +$154K | 0.72% | 40 |
|
|
2026
Q1 | $1.62M | Buy |
2,733
+2,658
| +3,544% | +$1.32M | 0.83% | 36 |
|
|
2025
Q4 | $36.5K | Hold |
75
| – | – | 0.02% | 95 |
|
|
2025
Q3 | $31.4K | Hold |
75
| – | – | 0.02% | 94 |
|
|
2025
Q2 | $21.6K | Hold |
75
| – | – | 0.01% | 116 |
|
|
2025
Q1 | $23.1K | Hold |
75
| – | – | 0.01% | 98 |
|
|
2024
Q4 | $26.5K | Sell |
75
-25
| -25% | -$9.19K | 0.01% | 97 |
|
|
2024
Q3 | $35.8K | Hold |
100
| – | – | 0.02% | 91 |
|
|
2024
Q2 | $31.9K | Hold |
100
| – | – | 0.02% | 90 |
|
|
2024
Q1 | $23K | Hold |
100
| – | – | 0.01% | 104 |
|
|
2023
Q4 | $22K | Hold |
100
| – | – | 0.01% | 101 |
|
|
2023
Q3 | $23K | Hold |
100
| – | – | 0.02% | 95 |
|
|
2023
Q2 | $22K | Hold |
100
| – | – | 0.01% | 97 |
|
|
2023
Q1 | $22K | Hold |
100
| – | – | 0.01% | 96 |
|
|
2022
Q4 | $28K | Hold |
100
| – | – | 0.02% | 91 |
|
|
2022
Q3 | $21K | Hold |
100
| – | – | 0.02% | 97 |
|
|
2022
Q2 | $24K | Hold |
100
| – | – | 0.02% | 95 |
|
|
2022
Q1 | $18K | Hold |
100
| – | – | 0.01% | 130 |
|
|
2021
Q4 | $22K | Buy |
100
+21
| +27% | +$4.12K | 0.01% | 129 |
|
|
2021
Q3 | $15K | Hold |
79
| – | – | 0.01% | 152 |
|
|
2021
Q2 | $14K | Hold |
79
| – | – | 0.01% | 116 |
|
|
2021
Q1 | $13K | Hold |
79
| – | – | 0.01% | 124 |
|
|
2020
Q4 | $12K | Hold |
79
| – | – | 0.01% | 123 |
|
|
2020
Q3 | $8K | Hold |
79
| – | – | 0.01% | 121 |
|
|
2020
Q2 | $10K | Hold |
79
| – | – | 0.01% | 101 |
|
|
2020
Q1 | $7K | Hold |
79
| – | – | 0.01% | 99 |
|
|
2019
Q4 | $7K | Hold |
79
| – | – | 0.01% | 120 |
|
|
2019
Q3 | $6K | Hold |
79
| – | – | 0.01% | 119 |
|
|
2019
Q2 | $6K | Hold |
79
| – | – | 0.01% | 116 |
|
|
2019
Q1 | $9K | Hold |
79
| – | – | 0.01% | 115 |
|
|
2018
Q4 | $9K | Hold |
79
| – | – | 0.01% | 113 |
|
|
2018
Q3 | $10K | Buy |
+79
| New | +$9.8K | 0.01% | 130 |
|
Other funds holding UTHR
Tower View Wealth Management's UTHR Position: Q2 2026 in Review
Tower View Wealth Management increased its United Therapeutics (UTHR) stake by 10% in Q2 2026, buying an estimated $154K and bringing the position to 3,006 shares worth $1.63M. The position accounts for 0.72% of the portfolio, ranked #40.
Tower View Wealth Management first reported a position in UTHR in Q3 2018 and has held it in 32 quarters since. 885 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Tower View Wealth Management held 3,006 shares of United Therapeutics worth $1.63M as of Q2 2026.
- Tower View Wealth Management bought 273 United Therapeutics shares in Q2 2026, an estimated $154K.
- United Therapeutics made up 0.72% of Tower View Wealth Management's portfolio in Q2 2026, its #40 holding.
- Tower View Wealth Management first reported a position in United Therapeutics in Q3 2018 and has held it in 32 quarters since.
- 885 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.